Shares of AT&T Inc. T, +0.98% inched 0.98% higher to $28.93 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX, +1.40% rising 1.40% to 4,224.79 and the Dow Jones Industrial Average DJIA, +1.76% rising 1.76% to 33,876.97. The stock’s rise snapped a three-day losing streak. AT&T Inc. closed $4.95 short of its 52-week high ($33.88), which the company achieved on May 17th.
Stocks jump about 3% in Japan after Monday’s selloff
Gold futures ended higher Monday, with the precious metal scoring a partial rebound from its steepest weekly decline since March 2020.
Jobs picture may call the tune as inflation fears ebb
To continue developing its stem-cell based treatment for heart failure, Tokyo-based Heartseed has raised 4 billion yen, or about $37 million U.S., in its latest venture capital round.
Even though the demand for COVID-19 testing may have passed its peak, the global need for diagnostics in preventive and routine care continues to grow—and now Novo Holdings wants to become further entrenched in the space.
VectorY Therapeutics has raised €31 million ($38 million) to fund preclinical work on gene therapies against amyotrophic lateral sclerosis (ALS) and Alzhiemer’s disease. Forbion led the seed financing in the Dutch developer of vectorized antibodies with the support of other investors including Eli Lilly.
Lucid’s regulatory dreams come true with European approval for esophageal cancer test for people with chronic heartburn
People at a higher risk of contracting esophageal cancer—including those with chronic heartburn and acid reflux—now have a clear pathway to an early diagnosis.
Umoja Biopharma emerged last November with $53 million and a mission to push past the limits of today’s immunotherapies. Now, the company is topping that haul by raising another $210 million to get its lead programs in bone cancer and blood cancer into the clinic.
CAMP4 Therapeutics, named for the camp closest to the top of Mount Everest, scaled closer to the peak of its solo mission Tuesday with $45 million in fresh capital.